Diet, lifestyle, and nonstatin trials: Review of time to benefit

American Journal of Cardiology

Volumn 96, Issue 5 SUPPL., 2005, Pages 3-10

  Denke, Margo A ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFIBRATE; COLESTYRAMINE; DEXTROTHYROXINE; ESTROGEN; NICOTINIC ACID; OMEGA 3 FATTY ACID;

ATHEROSCLEROSIS; CLINICAL RESEARCH; CORONARY ARTERY DISEASE; DIET THERAPY; FATALITY; HEART REHABILITATION; HUMAN; INTESTINE BYPASS; LIFESTYLE; METHODOLOGY; PATIENT COUNSELING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING CESSATION; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 23944490715     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.06.014     Document Type: Article

References (51)

1. C.P. Cannon, E. Braunwald, C.H. McCabe, D.J. Rader, J.L. Rouleau, R. Belder, S.V. Joyal, K.A. Hill, M.A. Pfeffer, A.M. Skene Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
2. D. Hasdai, D.R. Holmes Jr, D.A. Criger, E.J. Topol, R.M. Califf, R.G. Wilcox, E. Paolasso, M. Simoons, J. Deckers, R.A. Harrington PURSUIT Trial Investigators Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide Am Heart J 139 2000 454 460
3. T. Moccetti, R. Malacrida, E. Pasotti, F. Sessa, M. Genomi, S. Barlera, F. Turazza, A.P. Maggioni Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) Epidemiologic variables and outcome of 1972 young patients with acute myocardial infarction data from the GISSI-2 database Arch Intern Med 157 1997 865 869
4. P. Leren The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction a controlled clinical trial Bull N Y Acad Med 44 1968 1012 1020
5. S. Dayton, M.L. Pearce, S. Hashimoto, W.J. Dixon, U. Tomiyasu A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis Circulation 40 suppl II 1969 1 63
6. L.A. Carlson, G. Rosenhamer Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid Acta Med Scand 223 1988 405 418
7. O. Turpeinen, M. Miettinen, M.J. Karvonen, P. Roine, M. Pekkarinen, E.J. Lehtosuo, P. Alivirta Dietary prevention of coronary heart disease: long-term experiment, I. Observations on male subjects Am J Clin Nutr 21 1968 255 276
8. M. Miettinen, O. Turpeinen, M.J. Karvonen, R. Elosuo, E. Paavilainen Effects of cholesterol-lowering diet on mortality from coronary heart-disease and other causes a twelve-year clinical trial in men and women Lancet 2 1972 835 838
9. M. Miettinen, O. Turpeinen, M.J. Karvonen, M. Pekkarinen, E. Paavilainen, R. Elosuo Dietary prevention of coronary heart disease in women the Finnish Mental Hospital Study Int J Epidemiol 12 1983 17 25
10. O. Turpeinen Effect of cholesterol-lowering diet on mortality from coronary heart disease and other causes Circulation 59 1979 1 7
11. I.D. Frantz Jr, E.A. Dawson, P.L. Ashman, L.C. Gatewood, G.E. Bartsch, K. Kuba, E.R. Brewer Test of effect of lipid lowering by diet on cardiovascular risk the Minnesota Coronary Survey Arteriosclerosis 9 1989 129 135
12. Research Committee Low-fat diet in myocardial infarction a controlled trial Lancet 2 1965 501 504
13. Research Committee to the Medical Research Council Controlled trial of soya-bean oil in myocardial infarction Lancet 2 1968 693 699
14. G.A. Rose, W.B. Thomson, R.T. Williams Corn oil in treatment of ischaemic heart disease BMJ 544 1965 1531 1533
15. J.M. Woodhill, A.J. Palmer, B. Leelarthaepin, C. McGilchrist, R.B. Blacket Low fat, low cholesterol diet in secondary prevention of coronary heart disease Adv Exp Med Biol 109 1978 317 330
16. M.L. Burr, A.M. Fehily, J.F. Gilbert, S. Rogers, R.M. Holliday, P.M. Sweetnam, P.C. Elwood, N.M. Deadman Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction Diet and Reinfarction Trial (DART) Lancet 2 1989 757 761
17. R.B. Singh, S.S. Rastogi, R. Verma, B. Laxmi, R. Singh, S. Ghosh, M.A. Niaz Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction results of one year follow up BMJ 304 1992 1015 1019
18. R.B. Singh, G. Dubnov, M.A. Niaz, S. Ghosh, R. Singh, S.S. Rastogi, O. Manor, D. Pella, E.M. Berry Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study) a randomized single-blind trial Lancet 360 2002 1455 1461
19. M. de Lorgeril, S. Renaud, N. Mamelle, P. Salen, J.L. Martin, I. Monjaud, J. Guidollet, P. Touboul, J. Delaye Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease Lancet 343 1994 1454 1459
20. GISSI-Prevenzione Investigators Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico Lancet 354 1999 447 455
21. M. de Lorgeril, P. Salen, J.L. Martin, I. Monjaud, J. Delaye, N. Mamelle Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction final report of the Lyon Diet Heart Study Circulation 99 1999 779 785
22. M. de Lorgeril, P. Salen, J.L. Martin, N. Mamelle, I. Monjaud, P. Touboul, J. Delaye Effect of a mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease insights into the cardioprotective effect of certain nutriments J Am Coll Cardiol 28 1996 1103 1108
23. R. Marchioli, F. Barzi, E. Bomba, C. Chieffo, D. Di Gregorio, R. Di Mascio, M.G. Franzosi, E. Geraci, G. Levantesi, A.P. Maggioni GISSI-Prevenzione Investigators Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione Circulation 105 2002 1897 1903
24. G. Lamm, H. Denolin, D. Dorossiev, Z. Pisa Rehabilitation and secondary prevention of patients after acute myocardial infarction WHO collaborative study Adv Cardiol 31 1982 107 111
25. N.B. Oldridge, G.H. Guyatt, M.E. Fischer, A.A. Rimm Cardiac rehabilitation after myocardial infarction combined experience of randomized clinical trials JAMA 260 1988 945 950
26. G.T. O'Connor, J.E. Buring, S. Yusuf, S.Z. Goldhaber, E.M. Olmstead, R.S. Paffenbarger Jr, C.H. Hennekens An overview of randomized trials of rehabilitation with exercise after myocardial infarction Circulation 80 1989 234 244
27. W.L. Haskell, E.L. Alderman, J.M. Fair, D.J. Maron, S.F. Mackey, H.R. Superko, P.T. Williams, I.M. Johnstone, M.A. Champagne, R.M. Krauss, J.W. Farquhar Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease the Stanford Coronary Risk Intervention Project (SCRIP) Circulation 89 1994 975 990
28. M.F. Attebring, M. Hartford, A. Hjalmarson, K. Caidahl, T. Karlsson, J. Herlitz Smoking habits and predictors of continued smoking in patients with acute coronary syndromes J Adv Nurs 46 2004 614 623
29. A.P. Maggioni, F. Piantodosi, G. Tognoni, E. Santoro, M.G. Franzosi Smoking is not a protective factor for patients with acute myocardial infarction the viewpoint of the GISSI-2 Study G Ital Cardiol 28 1998 970 978
30. D. Hasdai, D.R. Holmes Jr, D.A. Criger, E.J. Topol, R.M. Califf, R.G. Wilcox, E. Paolasso, M. Simoons, J. Deckers, R.A. Harrington PURSUIT Trial Investigators Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide Am Heart J 139 2000 454 460
31. G.K. Andrikopoulos, D.J. Richter, P.E. Dilaveris, A. Pipilis, A. Zaharoulis, J.E. Gialafos, P.K. Toutouzas, E.T. Chimonas In-hospital mortality of habitual cigarette smokers after acute myocardial infarction the "smoker's paradox" in a countrywide study Eur Heart J 22 2001 776 784
32. T.F. van Berkel, H. Boersma, J.W. Roos-Hesselink, R.A. Erdman, M.L. Simoons Impact of smoking cessation and smoking interventions in patients with coronary disease Eur Heart J 20 1999 1773 1782
33. J. Critchley, S. Capewell Smoking cessation for the secondary prevention of coronary heart disease Cochrane Database Syst Rev 1 2004 CD003041
34. R.E. Vlietstra, R.A. Kronmal, A. Oberman, R.L. Frye, T. Killip III. Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease report from the CASS registry JAMA 255 1986 1023 1027
35. L. Wilhelmsen, K. Pyorala, H. Wedel, T. Cook, T. Pedersen, J. Kjekshus Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S) impact of predicted risk on the benefit of cholesterol-lowering treatment Eur Heart J 22 2001 1119 1127
36. H. Buchwald, R.L. Varco, J.P. Matts, J.M. Long, L.L. Fitch, G.S. Campbell, M.B. Pearce, A.E. Yellin, W.A. Edmiston, R.D. Smink Jr POSCH Group Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) N Engl J Med 323 1990 946 955
37. Lipid Research Clinics Program The Lipid Research Clinics Coronary Primary Prevention Trial results, I reduction in incidence of coronary heart disease JAMA 251 1984 351 364
38. J. Stamler The Coronary Drug Project findings with regard to estrogen, dextrothyroxine, clofibrate and niacin Adv Exp Med Biol 82 1977 52 75
39. P.L. Canner, K.G. Berge, N.K. Wenger, J. Stamler, L. Friedman, R.J. Prineas, W. Friedewald Fifteen year mortality in Coronary Drug Project patients long-term benefit with niacin J Am Coll Cardiol 8 1986 1245 1255
40. L.A. Carlson, G. Rosenhamer Reduction of mortality in the Stockholm Ischeamic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid Acta Med Scand 223 1988 405 418
41. L.A. Carlson, M. Danielson, I. Ekberg, B. Klintemar, G. Rosenhamer Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid Atherosclerosis 28 1977 81 86
42. M.H. Frick, O.P. Heinonen, J.K. Huttunen, P. Koskinen, M. Manttari, V. Manninen Efficacy of gemfibrozil in dyslipidaemic subjects with suspected heart disease an ancillary study in the Helsinki Heart Study frame population Ann Med 25 1993 41 45
43. H.B. Rubins, S.J. Robins, D. Collins, C.L. Fye, J.W. Anderson, M.B. Elam, F.H. Faas, E. Linares, E.J. Schaefer, G. Schectman, T.J. Wilt, J. Wittes Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol N Engl J Med 341 1999 410 418
44. BIP Study Group Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease the Bezafibrate Infarction Prevention (BIP) Study Circulation 102 2000 21 27
45. R. Rauramaa, P. Halonen, S.B. Vaisanen, T.A. Lakka, A. Schmidt-Trucksass, A. Berg, I.M. Penttila, T. Rankinen, C. Bouchard Effects of aerobic physical exercise on inflammation and atherosclerosis in men. The DNASCO study: a six-year randomized, controlled trial Ann Intern Med 140 2004 1007 1014
46. R.V. Milani, C.J. Lavie, M.R. Mehra Reduction in C-reactive protein through cardiac rehabilitation and exercise training J Am Coll Cardiol 43 2004 1056 1061
47. B.J. Nicklas, W. Ambrosius, S.P. Messier, G.D. Miller, B.W. Penninx, R.F. Loeser, S. Palla, E. Bleecker, M. Pahor Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults a randomized controlled clinical trial Am J Clin Nutr 79 2004 544 551
48. M.A. Crook, D.A. Scott, J.A. Stapleton, R.M. Palmer, R.F. Wilson, G. Sutherland Circulating concentration of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessation Eur J Clin Invest 30 2000 861 865
49. R.W. Peters, M.M. Brooks, L. Todd, P.R. Liebson, L. Wilhelmsen Cardiac Arrhythmia Suppression Trial (CAST) Investigators Smoking cessation and arrhythmic death the CAST experience J Am Coll Cardiol 26 1995 1287 1292
50. J.H. Christensen, E.B. Schmidt n-3 fatty acids and the risk of sudden cardiac death Lipids 36 suppl 2001 S115 S118
51. H.C. Bucher, P. Hengstler, C. Schindler, G. Meier N-3 polyunsaturated fatty acids in coronary heart disease a meta-analysis of randomized controlled trials Am J Med 112 2002 298 304